<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE LIFECORE BIOMEDICAL, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED DECEMBER 31, 1996. </LEGEND> <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> JUN-30-1997 <PERIOD-START> JUL-01-1996 <PERIOD-END> DEC-31-1996 <CASH> 1,440,000 <SECURITIES> 32,843,000 <RECEIVABLES> 3,283,000 <ALLOWANCES> 311,000 <INVENTORY> 8,826,000 <CURRENT-ASSETS> 32,964,000 <PP&E> 13,990,000 <DEPRECIATION> 4,899,000 <TOTAL-ASSETS> 62,431,000 <CURRENT-LIABILITIES> 3,782,000 <BONDS> 7,070,000 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 124,000 <OTHER-SE> 51,455,000 <TOTAL-LIABILITY-AND-EQUITY> 62,431,000 <SALES> 8,252,000 <TOTAL-REVENUES> 8,252,000 <CGS> 4,609,000 <TOTAL-COSTS> 10,206,000 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 335,000 <INCOME-PRETAX> (1,197,000) <INCOME-TAX> 0 <INCOME-CONTINUING> (1,197,000) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (1,197,000) <EPS-PRIMARY> (.10) <EPS-DILUTED> (.10)